A Phase II Trial of Induction Carboplatin and Docetaxel Followed by Radiotherapy Then Consolidation Chemotherapy With Carboplatin and Docetaxel in Stage III, IV and Recurrent Endometrial Cancer.
Phase of Trial: Phase II
Latest Information Update: 30 Dec 2017
At a glance
- Drugs Carboplatin; Docetaxel
- Indications Endometrial cancer
- Focus Therapeutic Use
- 10 Nov 2010 Actual end date (Mar 2007) added as reported by ClinicalTrials.gov.
- 10 Nov 2010 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.
- 26 Jan 2010 Actual patient number (42) added as reported by ClinicalTrials.gov.